Foghorn Therapeutics Inc.FHTXNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank57
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-78.78M
Near historical average
Percentile
P57
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-79.00M
Historical baseline
PeriodValueYoY Change
2025$-78.78M+18.9%
2024$-97.17M+7.0%
2023$-104.45M+8.2%
2022$-113.82M-18.3%
2021$-96.19M-43.1%
2020$-67.20M-37.7%
2019$-48.80M-90.7%
2018$-25.59M-